Amsterdam - Hollande
Wim van den Brink (1952) was born in Hilversum and received his medical degree form the Vrije Universiteit Amsterdam in 1981. He trained in psychiatric epidemiology at Columbia University, New York from 1986 to 1987. In 1989, he received his PhD degree from the State University of Groningen cum laude (Supervisors; Prof. Robert Giel and Dr. Hans Omel and Dr. Cees Sloof). Since 1992 he is Professor of Psychiatry and Addiction at the Academic Medical Center of the University of Amsterdam (AMC-UvA). He also holds the position of Director of the Amsterdam Institute for Addiction Research (AIAR). His research aims to uncover the neurobiological processes involved in the development of addictive behaviours and the effects of neurobiological interventions to prevent relapse in alcohol and drug dependent patients and pathological gamblers using neuropsychological tests, neurophysiological procedures and/or neuroimaging techniques. He chaired the working groups that developed multidisciplinary guidelines for the treatment of alcohol dependence (2009) and opioid dependence (2013) in The Netherlands. He has been the co-founder and president of the European Association of Substance Abuse Research (EASAR: 1995-2010). He is the chair of the International Collaboration of ADHD and Substance Abuse (ICASA: 2005-present) and the chair of the Scientific Program Committee of the European College of Neuropsychopharmacology (ECNP). He is a (co)author of over 400 peerreviewed scientific publications and he supervised 55 PhD students. Prof. Wim van den Brink is editor of European Addiction Research and associate editor of Drug and Alcohol Dependence. In addition, he is a member of the editorial board of Addiction, Addiction Biology, Current Drug Abuse Reviews, International Journal of Methods in Psychiatric Research, Mind and Brain, and Sucht.